[JIANG, Tao 江涛, ZENG, Lijie 曾利杰, WEN, Deyuan 温德源, ZENG, Chen 曾晨, CHEN, Lisi 陈丽斯, SU, Ruihui 苏锐辉, TANG, Yingzhan 汤迎湛, WANG, Chuanyi 王川易, PENG, Hongying 彭红英, FANG, Yuxin 方毓新, LIANG, Mingji 梁铭基, TANG, Donglan 唐冬兰] No.179 Renmin South Road, Liwan District 中国广东省广州市荔湾区人民南路179号, Guangdong 510130Guangzhou, Guangdong 510130 A Chinese patent medicine preparation for tonifying qi and nourishing blood and a preparation method therefor. The Chinese patent medicine preparation is prepared by the following traditional Chinese medicine raw materials in parts by weight: 139 parts of Polygonum multiflorum, 113.5 parts of Radix Rehmanniae Praeparata, 172 parts of Chinese Wolfberry Root Bark, 103.5 parts of Radix Rehmanniae, 172 parts of Poria cocos, 103.5 parts of Radix Asparagi, 103.5 parts of Radix Ophiopogonis, and 103 parts of Ginseng. The preparation method comprises steps of adding a specific type and amount of grinding aid and liquid nitrogen freezing in the process of treating the traditional Chinese medicine raw materials. A Chinese patent medicine preparation for tonifying qi and nourishing blood and a preparation method therefor. The Chinese patent medicine preparation is prepared by the following traditional Chinese medicine raw materials in parts by weight: 139 parts of Polygonum multiflorum, 113.5 parts of Radix Rehmanniae Praeparata, 172 parts of Chinese Wolfberry Root Bark, 103.5 parts of Radix Rehmanniae, 172 parts of Poria cocos, 103.5 parts of Radix Asparagi, 103.5 parts of Radix Ophiopogonis, and 103 parts of Ginseng. The preparation method comprises steps of adding a specific type and amount of grinding aid and liquid nitrogen freezing in the process of treating the traditional Chinese medicine raw materials.

[TANG, Yingzhan 汤迎湛, JIANG, Tao 江涛, ZENG, Lijie 曾利杰, ZENG, Chen 曾晨, ZHANG, Luyong 张陆勇, LIU, Juyan 刘菊妍, MA, Saiyan 马赛妍, CHEN, Qiming 陈启明, SU, Ruihui 苏锐辉, CHEN, Lisi 陈丽斯, WANG, Chuanyi 王川易, PENG, Hongying 彭红英] No.179 Renmin South Road, Liwan District 中国广东省广州市荔湾区人民南路179号, Guangdong 510130Guangzhou, Guangdong 510130 A pharmaceutical composition comprising astilbin and/or an isomer thereof for treating psoriasis, as well as a preparation and an application thereof. The pharmaceutical composition further comprises a polyphenol selected from the following: one or more of engeletin or an isomer thereof, taxifolin, naringenin, quercetin, and resveratrol. The pharmaceutical composition has significant therapeutic effects for an imiquimod-induced psoriasis-like mouse model and a mouse tail scale model. The combination of astilbin and/or an isomer thereof and a polyphenol in the pharmaceutical composition has a significant synergistic effect, and the effect thereof is better than that of using astilbin alone. Furthermore, the pharmaceutical composition is safe and has no adverse reactions, has broad application prospects in the preparation of drugs for treating psoriasis, and has important social and economic benefits.

[JIANG TAO, ZENG LIJIE, WEN DEYUAN, ZENG CHEN, CHEN LISI, SU RUIHUI, TANG YINGZHAN, WANG CHUANYI, PENG HONGYING, FANG YUXIN, LIANG MINGJI, TANG DONGLAN] CN A Chinese patent medicine preparation for tonifying qi and nourishing blood and a preparation method therefor. The Chinese patent medicine preparation is prepared by the following traditional Chinese medicine raw materials in parts by weight: 139 parts of Polygonum multiflorum, 113.5 parts of Radix Rehmanniae Praeparata, 172 parts of Chinese Wolfberry Root Bark, 103.5 parts of Radix Rehmanniae, 172 parts of Poria cocos, 103.5 parts of Radix Asparagi, 103.5 parts of Radix Ophiopogonis, and 103 parts of Ginseng. The preparation method comprises steps of adding a specific type and amount of grinding aid and liquid nitrogen freezing in the process of treating the traditional Chinese medicine raw materials.

[ZHANG JIANXUN, LI PEIDONG, KE GAOGUO, GUO BAOTING, WANG PENGFEI, HU NANA, NIU XIAOKE, SU HAITAO, WEI SHUAILING, ZHANG QIANKUN, LI YANG, XIE LIUDAN, PENG YINGZHAN, CHEN SHANGZHI, MENG YAKUN, XU YUAN, CHEN BINGWEI, YANG XIAOJUN, WANG YUANHAO, BAO LEI, LI XIAODONG, DAI YINGJIE, HU TUANWEI, HUANG WEI, CHEN YUFEI] CN;CN Provided is a large-stroke adjustable support, relating to the technical field of bridge engineering. The support includes a lower support plate fixedly disposed at a top of a bridge pier, a height-adjusting mechanism disposed in the lower support plate, a pressure-bearing rubber plate fixedly disposed in a containing slot, a middle steel linear plate fixedly disposed in the containing slot and located above the pressure-bearing rubber plate and an upper support plate located above a tractor and fixedly disposed at a bottom of a bridge beam; the height-adjusting mechanism includes a supporting member, the height-adjusting mechanism can drive the supporting member to reciprocate up and down, and the containing slot is formed in the supporting member; the tractor is universally connected above the middle steel linear plate; and a plane sliding plate is disposed between the tractor and the upper support plate.

[TANG, Yingzhan 汤迎湛, JIANG, Tao 江涛, ZENG, Chen 曾晨, SU, Ruihui 苏锐辉, ZENG, Lijie 曾利杰, WANG, Chuanyi 王川易, CHEN, Lisi 陈丽斯, PENG, Hongying 彭红英, WEN, Deyuan 温德源] No.179 Renmin South Road, Liwan District 中国广东省广州市荔湾区人民南路179号, Guangdong 510130Guangzhou, Guangdong 510130 A licorice charcoal coating material for reducing drug-induced hepatotoxicity, a preparation method therefor and use thereof. The coating material is licorice charcoal. The preparation method for licorice charcoal comprises: crushing pieces of licorice, sieving, stir-frying with high heat for 1-2 hours, spraying with clean water, sealing and cooling. The yield of licorice charcoal produced by the method is about 45%, which is about 10% higher than the highest yield reported in the literature. The obtained licorice charcoal is a black or grayish black powder with a mild odor and a slightly sweet taste, in which the impurity content is less than 3% and the water content is less than 10%. The licorice charcoal prepared by the method can effectively reduce drug-induced hepatotoxicity and can be used as a coating material for drugs with hepatotoxicity, reducing liver injury in patients after drug administration, and has a wide range of potential applications.

[TANG YINGZHAN, JIANG TAO, ZENG LIJIE, ZENG CHEN, ZHANG LUYONG, LIU JUYAN, MA SAIYAN, CHEN QIMING, SU RUIHUI, CHEN LISI, WANG CHUANYI, PENG HONGYING] CN A pharmaceutical composition comprising astilbin and/or an isomer thereof for treating psoriasis, as well as a preparation and an application thereof. The pharmaceutical composition further comprises a polyphenol selected from the following: one or more of engeletin or an isomer thereof, taxifolin, naringenin, quercetin, and resveratrol. The pharmaceutical composition has significant therapeutic effects for an imiquimod-induced psoriasis-like mouse model and a mouse tail scale model. The combination of astilbin and/or an isomer thereof and a polyphenol in the pharmaceutical composition has a significant synergistic effect, and the effect thereof is better than that of using astilbin alone. Furthermore, the pharmaceutical composition is safe and has no adverse reactions, has broad application prospects in the preparation of drugs for treating psoriasis, and has important social and economic benefits.